Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK-Reference-Cited by-同舟云学术

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Published:2008-07 Issue:7 Volume:19 Page:1288-1292
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Borner M.,Koeberle D.,Von Moos R.,Saletti P.,Rauch D.,Hess V.,Trojan A.,Helbling D.,Pestalozzi B.,Caspar C.,Ruhstaller T.,Roth A.,Kappeler A.,Dietrich D.,Lanz D.,Mingrone W.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/7/1288/912855/mdn058.pdf

Reference22 articles.

1. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N Engl J Med,2004

2. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

3. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor;Saltz;J Clin Oncol,2004

4. Epidermal growth factor receptor targeting in cancer;Mendelsohn;Semin Oncol,2006

5. Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer;Borner;J Clin Oncol,2002

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer;Biomedicine & Pharmacotherapy;2024-10

2. Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials;BMC Cancer;2024-07-24

3. Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment;International Immunopharmacology;2024-04

4. Case report: Interstitial lung disease of XELOEX chemotherapy with cetuximab in advanced colon cancer induced;Medicine;2023-12-15

5. Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches;Cancers;2023-10-30